Your browser doesn't support javascript.
loading
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.
Fletcher, Robert A; Herrington, William G; Agarwal, Rajiv; Mayne, Kaitlin J; Arnott, Clare; Jardine, Meg J; Mahaffey, Kenneth W; Perkovic, Vlado; Staplin, Natalie; Wheeler, David C; Chertow, Glenn M; Heerspink, Hiddo J L; Neuen, Brendon L.
Afiliação
  • Fletcher RA; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Herrington WG; Medical Research Council Population Health Research Unit at the University of Oxford, Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, United Kingdom.
  • Agarwal R; Clinical Trial Service Unit and Epidemiologic Studies Unit (CTSU), NDPH, University of Oxford, Oxford, United Kingdom.
  • Mayne KJ; Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Arnott C; Indiana University School of Medicine and VA Medical Center, Indianapolis, Indiana.
  • Jardine MJ; Medical Research Council Population Health Research Unit at the University of Oxford, Nuffield Department of Population Health (NDPH), University of Oxford, Oxford, United Kingdom.
  • Mahaffey KW; School of Cardiovascular and Metabolic Health, College of Medical and Veterinary Life Sciences, University of Glasgow, Glasgow, United Kingdom.
  • Perkovic V; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Staplin N; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Wheeler DC; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Chertow GM; NHMRC Clinical Trials Centre, University of Sydney, New South Wales, Australia.
  • Heerspink HJL; Department of Renal Medicine, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
  • Neuen BL; Department of Medicine, Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, California.
Clin J Am Soc Nephrol ; 2024 Apr 16.
Article em En | MEDLINE | ID: mdl-38622766
ABSTRACT
Clinical Trial registry name and registration number ClinicalTrials.gov Identifiers NCT02065791 (CREDENCE), NCT03036150 (DAPA-CKD), NCT03594110 (EMPA-KIDNEY).
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin J Am Soc Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália